학술논문
The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan
Document Type
Article
Author
Source
In: Journal of Personalized Medicine . (Journal of Personalized Medicine, February 2022, 12(2))
Subject
Language
English
ISSN
20754426